Pharmacokinetics of cephalexin in the horse after intravenous and intramuscular administration of two formulations. 2002

R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
Department of Veterinary Sciences and Technologies for Food Safety (USA), Faculty of Veterinary Medicine, Milan, Italy. roberto.villa@unimi.it

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover

Related Publications

R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
August 1996, New Zealand veterinary journal,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
May 1984, American journal of veterinary research,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
June 1985, Journal of veterinary pharmacology and therapeutics,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
January 1996, Acta veterinaria Hungarica,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
December 1985, Casopis lekaru ceskych,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
January 1983, Psychopharmacology,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
January 1986, Czechoslovak medicine,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
January 1988, The Veterinary record,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
December 1978, Antimicrobial agents and chemotherapy,
R Villa, and C Belloli, and P Cagnardi, and O Sonzogni, and S Bacchetta, and S Carli
February 2012, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!